Original Article

The Application Value of Combined Detection of Serum IL-6, LDH, S100, NSE, and GFAP in the Early Diagnosis of Brain Damage Caused by Neonatal Asphyxia


Background: We aimed to investigate the correlation and clinical significance between a group of serum biomarkers and brain damage caused by neonatal asphyxia, and to provide sensitive and effective detection methods for early diagnosis and prognosis improvement.

Methods: We enrolled neonates hospitalized in the neonatal department of The Affiliated Hospital of Inner Mongolia Medical University of China from June 2020 to June 2021 as the study subjects. The levels of interleukin-6 (IL-6), lactate dehydrogenase (LDH), S100 protein, neuron-specific enolase (NSE), and glial fibrillary acidic protein (GFAP) in serum samples were measured using electrochemiluminescence (ECL), enzyme-linked immunosorbent assay (ELISA) or rate method and the correlations between these serum biomarkers and the degree of neonatal asphyxia and brain damage were statistically analyzed using Spearman test.

Results: The levels of serum IL-6, LDH, S100, NSE, and GFAP in the neonatal asphyxia with brain damage group within 12 hours after birth were significantly higher than those in the neonatal asphyxia without brain damage group (all P<0.05). Additionally, these levels were positively correlated with the degree of asphyxia. The Area Under the Curve (AUC) of receiver operating characteristic (ROC) curves of IL-6 (0.8819), LDH (0.8108), S100 (0.8719), NSE (0.8719), and GFAP (0.8073) were revealed.

Conclusion: The combined detection of serum marker levels can simultaneously reflect neuronal injury, glial cell injury, and inflammatory injury, improve the accuracy of diagnosis of neonatal asphyxia with brain damage, and enable the formulation of treatment strategies as early as possible to reduce the incidence of complications of brain damage.


1. Welzel B, Schmidt R, Johne M, Loscher W (2023). Midazolam Prevents the Adverse Outcome of Neonatal Asphyxia. Ann Neurol, 93:226-243.
2. Bersani I, Gasparroni G, Bashir M, et al (2022). Early predictors of abnormal MRI patterns in asphyxiated infants: S100B protein urine levels. Clin Chem Lab Med, 60:1745-1752.
3. Zhang S, Li B, Zhang X, Zhu C, Wang X (2020). Birth Asphyxia Is Associated With Increased Risk of Cerebral Palsy: A Meta-Analysis. Front Neurol, 11:704.
4. Rutherford M, Ramenghi LA, Edwards AD, (2010). Assessment of brain tissue injury after moderate hypothermia in neonates with hypoxic-ischaemic encephalopathy: a nested substudy of a randomised controlled trial. Lancet Neurol, 9:39-45.
5. Bazarian JJ, Biberthaler P, Welch RD, et al (2018). Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study. Lancet Neurol, 17:782-789.
6. Zhao Y, Liu G, Liang L, et al (2022). Relationship of plasma MBP and 8-oxo-dG with brain damage in preterm. Open Med (Wars), 17:1674-1681.
7. Boskabadi H, Zakerihamidi M, Moradi A (2020). Predictive value of biochemical and hematological markers in prognosis of asphyxic infants. Caspian J Intern Med, 11:377-383.
8. Ruhfus M, Giannakis S, Markus M, et al (2021). Association of Routinely Measured Proinflammatory Biomarkers With Abnormal MRI Findings in Asphyxiated Neonates Undergoing Therapeutic Hypothermia. Front Pediatr, 9:624652.
9. Visser K, Koggel M, Blaauw J, et al (2022). Blood-based biomarkers of inflammation in mild traumatic brain injury: A systematic review. Neurosci Biobehav Rev, 132:154-168.
10. Yuan D, Guan S, Wang Z, et al (2021). HIF-1alpha aggravated traumatic brain injury by NLRP3 inflammasome-mediated pyroptosis and activation of microglia. J Chem Neuroanat, 116:101994.
11. Sun K, Zhang J, Yang Q, et al (2021). Dexmedetomidine exerts a protective effect on ischemic brain injury by inhibiting the P2X7R/NLRP3/Caspase-1 signaling pathway. Brain Res Bull, 174:11-21.
12. Luo C, Li B, Chen L, Zhao L, Wei Y (2021). IL-27 Protects the Brain from Ischemia-Reperfusion Injury via the gp130/STAT3 Signaling Pathway. J Mol Neurosci, 71:1838-1848.
13. Michetti F, D'Ambrosi N, Toesca A, et al (2019). The S100B story: from biomarker to active factor in neural injury. J Neurochem, 148:168-187.
14. Li M, Ye M, Zhang G (2021). Aberrant expression of miR-199a in newborns with hypoxic-ischemic encephalopathy and its diagnostic and prognostic significance when combined with S100B and NSE. Acta Neurol Belg, 121:707-714.
15. Irmak K, Tuten N, Karaoglu G, et al (2021). Evaluation of cord blood creatine kinase (CK), cardiac troponin T (cTnT), N-terminal-pro-B-type natriuretic peptide (NT-proBNP), and s100B levels in nonreassuring foetal heart rate. J Matern Fetal Neonatal Med, 34:1249-1254.
16. Dieckmann L, Lahti-Pulkkinen M, Kvist T, et al (2021). Characteristics of epigenetic aging across gestational and perinatal tissues. Clin Epigenetics, 13:97.
17. Morin AM, Gatev E, McEwen LM, et al (2017). Maternal blood contamination of collected cord blood can be identified using DNA methylation at three CpGs. Clin Epigenetics, 9:75.
18. Okonkwo DO, Puffer RC, Puccio AM, et al (2020). Point-of-Care Platform Blood Biomarker Testing of Glial Fibrillary Acidic Protein versus S100 Calcium-Binding Protein B for Prediction of Traumatic Brain Injuries: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Study. J Neurotrauma, 37:2460-2467.
19. Huang L, Guo X, Liu P, et al (2022). Correlation between acute brain injury and brain metabonomics in dichlorvos-poisoned broilers. J Hazard Mater, 422:126849.
20. Abdelhak A, Foschi M, Abu-Rumeileh S, et al (2022). Blood GFAP as an emerging biomarker in brain and spinal cord disorders. Nat Rev Neurol, 18:158-172.
21. Rogan A, O'Sullivan MB, Holley A, McQuade D, Larsen P (2022). Can serum biomarkers be used to rule out significant intracranial pathology in emergency department patients with mild traumatic brain injury? A Systemic Review & Meta-Analysis. Injury, 53:259-271.
22. Whitehouse DP, Monteiro M, Czeiter E, et al (2022). Relationship of admission blood proteomic biomarkers levels to lesion type and lesion burden in traumatic brain injury: A CENTER-TBI study. EBioMedicine, 75:103777.
23. Liu XM, Liu XH, Mao MJ, et al (2021). The automated processing algorithm to correct the test result of serum neuron-specific enolase affected by specimen hemolysis. J Clin Lab Anal, 35:e23895.
24. Bersani I, Pluchinotta F, Dotta A, Savarese I, Campi F, Auriti C, Chuklantseva N, Piersigilli F, Gazzolo F, Varrica A, Satriano A, Gazzolo D (2020). Early predictors of perinatal brain damage: the role of neurobiomarkers. Clin Chem Lab Med, 58:471-486.
IssueVol 52 No 11 (2023) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/ijph.v52i11.14036
Neonate asphyxia Brain damage Early diagnosis Serum marker

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Liu B, Lan H, Gao N, Hu G. The Application Value of Combined Detection of Serum IL-6, LDH, S100, NSE, and GFAP in the Early Diagnosis of Brain Damage Caused by Neonatal Asphyxia. Iran J Public Health. 2023;52(11):2363-2371.